<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896912444158</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896912444158</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>CD25 Is a Novel Marker of Hepatic Bile Canaliculus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lu</surname><given-names>Zhong-Hua</given-names></name>
<degrees>MMed</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>-Chen</surname><given-names>Wei</given-names></name>
<degrees>BM</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ju</surname><given-names>Chao-Xia</given-names></name>
<degrees>BM</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>-Den</surname><given-names>Jun</given-names></name>
<degrees>BM</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kuai</surname><given-names>Shou-gang</given-names></name>
<degrees>MMed</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pei</surname><given-names>Hao</given-names></name>
<degrees>BM</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname><given-names>Li-Hua</given-names></name>
<degrees>MMed</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gu</surname><given-names>Xi-Bing</given-names></name>
<degrees>BM</degrees>
<xref ref-type="aff" rid="aff1-1066896912444158">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ying</surname><given-names>Yong-Xiang</given-names></name>
<degrees>MMed</degrees>
<xref ref-type="aff" rid="aff2-1066896912444158">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname><given-names>Xi-Qi</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-1066896912444158">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhu</surname><given-names>Teng-Fang</given-names></name>
<degrees>BM</degrees>
<xref ref-type="aff" rid="aff3-1066896912444158">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xing</surname><given-names>Yi-Ping</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1066896912444158">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fan</surname><given-names>Qin-He</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1066896912444158">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896912444158"><label>1</label>Hepatology Research Institute, Contagious Hospital, Wuxi, Jiangsu Province, China</aff>
<aff id="aff2-1066896912444158"><label>2</label>Maternity &amp; Child Care Center, Wuxi, Jiangsu Province, China</aff>
<aff id="aff3-1066896912444158"><label>3</label>Fudan University Shanghai Medical School, Shanghai, China</aff>
<aff id="aff4-1066896912444158"><label>4</label>The First Affiliated Hospital, Nanjing Medical University, Nanjing, China</aff>
<author-notes>
<corresp id="corresp1-1066896912444158">Zhong-Hua Lu, Hepatology Research Institute, Wuxi Contagious Hospital, Xingyuan Zhong Road 88, Wuxi, Jiangsu Province, 214005, China Email: <email>lu_z_h@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>5</issue>
<fpage>455</fpage>
<lpage>461</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Objective</italic>. Although many antigens have been investigated, the method for the bile canaliculus staining using optical microscopy needs to be improved. The aim of the present study was to assess the expression pattern of a candidate marker, CD25, in normal and diseased liver tissue. <italic>Methods</italic>. Immunohistochemistry, immunofluorescence, and immune electron microscopy assays were performed with 41 liver sections and 2 different anti-CD25 monoclonal antibodies. A polyclonal antibody against carcinoembryonic antigen (CEA) was also used to stain bile canaliculus as a control. CD25 expression levels in normal and diseased liver tissue were also determined. <italic>Results</italic>. CD25 was predominantly localized at the bile canaliculus of adult and infantile liver, evidenced by both immunohistochemistry and immunofluorescence assays. The electron microscopy assay showed that there were obvious amorphous electron-dense deposits at the bile canaliculus. In contrast, the CEA-positive area included bile canaliculus as well as basolateral aspects of hepatocytes. CD25 expression levels did not differ significantly among different disease states. <italic>Conclusion</italic>. This study provides the first evidence that CD25 is a novel marker of bile canaliculus. Characteristics of CD25 expression may shed light on immunohistochemistry and immunofluorescence analysis of bile canaliculus in both basic and clinical hepatic investigations.</p>
</abstract>
<kwd-group>
<kwd>CD25</kwd>
<kwd>marker</kwd>
<kwd>hepatic bile canaliculus</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896912444158" sec-type="intro">
<title>Introduction</title>
<p>The liver plays an active role in the clearance of systemic endotoxins. Hepatocytes are polarized epithelial cells that make up 70% to 80% of the liver’s cytoplasmic mass. Hepatocytes have distinct structural features representative of their apical domain. Bile canaliculus are approximately 0.7 to 0.8 µm in diameter,<sup><xref ref-type="bibr" rid="bibr1-1066896912444158">1</xref></sup> and are formed by the apposing membranes of contiguous hepatocytes. They are delimited by tight-junction complexes. Paracellular exchange is permitted between plasma and the canaliculus.<sup><xref ref-type="bibr" rid="bibr2-1066896912444158">2</xref></sup> The bile canaliculi merge and form bile ductules, which eventually become the common hepatic duct. In the internal wall of bile canaliculus, there are many canalicular microvilli, which are about 0.5 to 1.0 µm long and 0.1 µm in diameter, that contain arrays of actin filaments and extend from the plasma membrane surface into the canalicular space.<sup><xref ref-type="bibr" rid="bibr2-1066896912444158">2</xref></sup> The bile ducts not only represent pipelines of bile acid but also may dynamically contribute to liver functions.<sup><xref ref-type="bibr" rid="bibr2-1066896912444158">2</xref></sup> Bile formation at the canalicular membrane is a delicate process and malfunction of bile canaliculi may have devastating consequences and lead to the development of liver disease.<sup><xref ref-type="bibr" rid="bibr3-1066896912444158">3</xref></sup> Therefore, illustrating or identifying bile canaliculus using microscopy is very important in liver diseases studies.</p>
<p>More than 40 years ago, enzyme histochemists incubated microtome sections of mammalian liver with ATP and lead (Gomori reaction) and observed a lead phosphate precipitation that identified the “chicken-wire” appearance of the bile canaliculus.<sup><xref ref-type="bibr" rid="bibr4-1066896912444158">4</xref></sup> After its invention, electron microscopy was thought to be the best method for illustrating bile canaliculus.<sup><xref ref-type="bibr" rid="bibr5-1066896912444158">5</xref>,<xref ref-type="bibr" rid="bibr6-1066896912444158">6</xref></sup> However, as electron microscopy is difficult to perform, the most common morphological method for lab investigation of tissue remains immunochemistry or immunofluorescence assays. Many antigens, including carcinoembryonic antigen (CEA),<sup><xref ref-type="bibr" rid="bibr7-1066896912444158">7</xref>,<xref ref-type="bibr" rid="bibr8-1066896912444158">8</xref></sup> F-actin,<sup><xref ref-type="bibr" rid="bibr9-1066896912444158">9</xref></sup> bile salt transporter (BSEP),<sup><xref ref-type="bibr" rid="bibr10-1066896912444158">10</xref>,<xref ref-type="bibr" rid="bibr11-1066896912444158">11</xref></sup> organic anion transporter (MRP2),<sup><xref ref-type="bibr" rid="bibr12-1066896912444158">12</xref></sup> and phosphatidylcholine transporter (MDR1 or MDR3)<sup><xref ref-type="bibr" rid="bibr10-1066896912444158">10</xref></sup> have been used to indicate bile canaliculus in diverse publications. However, the method for the bile canaliculus staining using optical microscopy needs to be improved.</p>
<p>CD25 is the α chain of the interleukin-2 (IL-2) receptor and is expressed on activated T cells, activated B cells, some thymocytes, myeloid precursors, and oligodendrocytes that associate with CD122 to form a heterodimer that can act as a high-affinity receptor for IL-2 (IL-2R).<sup><xref ref-type="bibr" rid="bibr13-1066896912444158">13</xref><xref ref-type="bibr" rid="bibr14-1066896912444158"/>-<xref ref-type="bibr" rid="bibr15-1066896912444158">15</xref></sup> IL-2R consists typically of 3 receptor subunits named IL-2Rα (CD25), IL-2Rβ (CD122), and the common gamma chain (γc, CD132). It is believed that CD122 and γc are crucial for signal transduction of IL-2, whereas CD25 is nonessential for IL-2 signaling but instead confers high-affinity binding of IL-2 to its receptor, thereby increasing receptor affinities by approximately 100-fold.<sup><xref ref-type="bibr" rid="bibr13-1066896912444158">13</xref>,<xref ref-type="bibr" rid="bibr14-1066896912444158">14</xref></sup> CD25 is mainly expressed in a portion of the activated immune cells, especially in regular T cells, in certain forms of lymphoid neoplasia and select autoimmune diseases, and in individuals rejecting allografts.<sup><xref ref-type="bibr" rid="bibr13-1066896912444158">13</xref></sup> Given this natural link between CD25 and the immune system, studies on CD25 in liver have mainly focused on the role of CD25<sup>+</sup> T regular cells in chronic viral hepatitis, autoimmune hepatitis, and liver transplantation.<sup><xref ref-type="bibr" rid="bibr16-1066896912444158">16</xref></sup> In fact, numerous reports suggest that CD25 is a critical marker for systemic regulatory T cells.<sup><xref ref-type="bibr" rid="bibr17-1066896912444158">17</xref>,<xref ref-type="bibr" rid="bibr18-1066896912444158">18</xref></sup> However, research results regarding the expression of CD25 in hepatic cells are largely unclear.</p>
<p>Here, we assess the potential of CD25 as a novel marker of bile canaliculus via immunochemistry, immunofluorescence, and immune electron microscopy assays. We also investigated hepatic CD25 expression levels in tissue from patients diagnosed with liver disease and normal specimens. Additionally, we studied the expression of CD122 in bile canaliculus. CD122 is also known as IL-2Rβ and coordinately with IL-2 signaling pathway transduction.</p>
</sec>
<sec id="section2-1066896912444158" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1066896912444158">
<title>Reagents</title>
<p>The EnVision kit was purchased from Dako (Glostrup, Denmark). The 2 mouse anti-CD25 monoclonal antibodies were purchased from Labvision (clone IL2R.1, Fremont, CA) and Zymed (clone 4c9, South San Francisco, CA). The rabbit anti-CD122 polyclonal antibody was purchased from Abcam (Cambridge, UK). The rabbit anti-carcinoembryonic antigen (p-CEA) polyclonal antibody was purchased from Zymed (South San Francisco, CA). FITC-conjugated goat mouse anti-IgG was purchased from Jackson ImmunoResearch (West Grove, PA).</p>
</sec>
<sec id="section4-1066896912444158">
<title>Samples</title>
<p>Sections used in this study were from tissue procured during liver biopsy at our hospital from 2005 to 2007, and included 20 hepatitis B patients (n = 3 in Scheuer G1 stage; n = 4 in Scheuer G2 stage; n = 9 in Scheuer G3 stage; n = 4 in Scheuer G4 stage<sup><xref ref-type="bibr" rid="bibr19-1066896912444158">19</xref></sup>), 10 patients with primary biliary cirrhosis, 5 patients with drug-induced hepatitis, and 2 patients with chronic rejection after liver transplantation. Biopsies were originally collected to aid in the diagnosis of liver disease, to assess the severity of known liver disease, or to monitor the progress of treatment. Paraffin sections were stored at −80°C for years. Two normal liver tissues were obtained from previously healthy organ donors for liver transplantation. Two infantile liver tissues were obtained from Wuxi Women and Children Hospital. Written informed consent was obtained from individual patients and the experimental protocol was approved by the hospital’s ethic committee.</p>
</sec>
<sec id="section5-1066896912444158">
<title>Immunohistochemistry</title>
<p>Immunohistochemical analysis was conducted as described previously.<sup><xref ref-type="bibr" rid="bibr20-1066896912444158">20</xref>,<xref ref-type="bibr" rid="bibr21-1066896912444158">21</xref></sup> Briefly, liver tissues were fixed in 10% neutral buffered formalin for more than 24 hours. Tissues were processed for routine histopathological examination by dehydrating in a sequence of 50%, 70%, 95%, and 100% ethanol and then embedded in paraffin and 5-µm thick histologic sections were prepared with a Leica CM1900 microtome (Leica Microsystems, Wetzlar, Germany). Paraffin was removed with xylene, and tissues were equilibrated in Tris-buffered saline (TBS). Heat-mediated antigen retrieval (HMAR) was performed using a domestic pressure cooker. Endogenous peroxidase was blocked with hydrogen peroxide (0.5% in methanol) for 15 minutes. To block nonspecific binding, slides were incubated for 1 hour at room temperature in TBS containing 2% (w/v) normal goat serum. Incubation with primary antibodies (mouse anti-CD25 monoclonal antibody, clone IL2R.1, 1:200; mouse anti-CD25 monoclonal antibody, clone 4c9, 1:200; rabbit anti-CD122 polyclonal antibody, 1:200; rabbit anti-carcinoembryonic antigen [p-CEA] polyclonal antibody, 1:200) was carried out in a humidified chamber overnight at 4°C. Slides were rinsed and incubated for 1 hour at room temperature then with EnVision A solution for 20 minutes, and then washed 3 times in PBS. Slides were then rinsed and incubated at room temperature for 30 minutes with EnVision B solution. After the DAB staining, tissues were counterstained with hematoxylin and dehydrated. Negative controls were obtained in each instance by omitting the primary antibody. Micrographs were taken using a Leica DM LB2 microscopic lens.</p>
</sec>
<sec id="section6-1066896912444158">
<title>Immunofluorescence</title>
<p>The immunofluorescence assay was performed as described previously.<sup><xref ref-type="bibr" rid="bibr22-1066896912444158">22</xref>,<xref ref-type="bibr" rid="bibr23-1066896912444158">23</xref></sup> Briefly, 5 µm thick coronal sections were blocked by 1% bovine serum albumin (BSA) for 30 minutes after which they were incubated overnight at 4°C with a single anti-CD25 (1: 200) antibody. After being washed in PBS 3 times, they were incubated with FITC-conjugated goat mouse anti-IgG (Jackson Immunoresearch, West Grove, PA) at room temperature for 30 minutes. The sections were visualized with a fluorescence microscope (465-495 nm), and images were captured.</p>
</sec>
<sec id="section7-1066896912444158">
<title>Immunoelectron Microscopy</title>
<p>Immunoelectron microscopy analysis was performed as described previously.<sup><xref ref-type="bibr" rid="bibr24-1066896912444158">24</xref></sup> After immunohistochemistry staining, sections for immunoelectron microscopic immunohistochemistry were postfixed in 1% osmium tetroxide for 1 hour, and dehydrated through graded alcohol and propylene oxide (50% alcohol–70% alcohol–80% alcohol–90% alcohol–90% alcohol plus 90% propylene oxide–absolute propylene oxide). Then, the sections were embedded in epoxide resin. Ultrathin sections (50 nm) were cut on a Leica Ultramicrotome (Leica, Deerfield, IL). They were stained by lead citrate and examined on in a Hitachi H-500 electron microscope. Control sections were processed in parallel, in which the primary antibody was either omitted or preabsorbed with the corresponding antigen.</p>
</sec>
<sec id="section8-1066896912444158">
<title>Statistical Analysis</title>
<p>Data are expressed as mean ± standard deviation (SD). The average optical density (OD) of every section was determined with Image J software (NIH, version 1.4). Differences were evaluated using the Mann–Whitney <italic>U</italic> test (SPSS, versiom 7.0, Chicago, IL). Statistical significance was set at <italic>P</italic> &lt; .05.</p>
</sec>
</sec>
<sec id="section9-1066896912444158" sec-type="results">
<title>Results</title>
<sec id="section10-1066896912444158">
<title>Immunohistochemistry Analysis of CD25</title>
<p>Liver sections immunostained with the 2 different mouse anti-CD25 monoclonal antibodies (clone numbers: IL2R.1 and 4c9) generated similar results. No positive cells were observer in the negative controls (in which the primary antibody was omitted). As shown in <xref ref-type="fig" rid="fig1-1066896912444158">Figure 1A</xref> (200×) and 1B (400×), the tube-like bile canaliculi were clearly stained when either monoclonal antibody was used (blue arrow).</p>
<fig id="fig1-1066896912444158" position="float">
<label>Figure 1.</label>
<caption>
<p>CD25 and carcinoembryonic antigen (CEA) immunostaining of bile canaliculus</p>
<p>(A) A canalicular staining pattern was observed after immunohistochemistry with a mouse anti-CD25 monoclonal antibody (clone IL2R.1, 1:200, Labvision). Magnification, 200× (blue arrow). (B) A similar canalicular staining pattern was also observed after immunohistochemistry with a different mouse anti-CD25 monoclonal antibody (clone 4c9, 1:200, Zymed). Magnification: 400× (blue arrow). (C) Liver tissue immunostained for CEA using a polyclonal antibody (1:200, Zymed). Blue arrows indicate the basolateral aspects of hepatocytes. Magnification: 200×.</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig1.tif"/>
</fig>
<p>Immunochemistry was also conducted using the p-CEA antibody. As shown in <xref ref-type="fig" rid="fig1-1066896912444158">Figure 1C</xref> (200×), positive brown staining was observed among tube-like bile canaliculi as well as basolateral aspects of hepatocytes (blue arrows).</p>
<p>We also observed the CD25 expression in infants and children. In the liver tissue obtained from a 26-week gestation fetus, CD25 expression in bile canaliculi was rather weak (<xref ref-type="fig" rid="fig2-1066896912444158">Figure 2</xref>; 200×). In liver tissues obtained from neonate, CD25 expression was apparent in bile canaliculi (<xref ref-type="fig" rid="fig3-1066896912444158">Figure 3</xref>; 200×).</p>
<fig id="fig2-1066896912444158" position="float">
<label>Figure 2.</label>
<caption>
<p>In the liver tissue obtained from a 26-week gestation fetus, CD25 expression in bile canaliculi was rather weak. Magnification: 200× (blue arrow)</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig2.tif"/>
</fig>
<fig id="fig3-1066896912444158" position="float">
<label>Figure 3.</label>
<caption>
<p>In liver tissues obtained from a neonate, CD25 expression was apparent in bile canaliculi. Magnification: 200× (blue arrow)</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig3.tif"/>
</fig>
</sec>
<sec id="section11-1066896912444158">
<title>Immunohistochemistry Analysis of CD122</title>
<p>We also studied the expression of CD122, the β chain of IL-2R. CD122 was expressed widely in liver tissue (<xref ref-type="fig" rid="fig4-1066896912444158">Figure 4</xref>; 200×) and the specificity was scarce.</p>
<fig id="fig4-1066896912444158" position="float">
<label>Figure 4.</label>
<caption>
<p>The expression of rabbit anti-CD122(1:200, Abcam), the β chain of IL-2R. CD122 expression in bile canaliculi was rather dull (blue arrow) and the specificity was scarce (green arrow). Magnification: 200×</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig4.tif"/>
</fig>
</sec>
<sec id="section12-1066896912444158">
<title>Immunofluorescence Analysis of CD25</title>
<p>Immunofluorescence analysis was also performed on adjacent sections. As showed in <xref ref-type="fig" rid="fig5-1066896912444158">Figure 5A</xref> (200×) and 5B (400×), incubation with either mouse anti-CD25 monoclonal antibody (clone number: IL2R.1 or 4c9) resulted in clear positive staining (green) of the tube-like bile canaliculi (blue arrow).</p>
<fig id="fig5-1066896912444158" position="float">
<label>Figure 5.</label>
<caption>
<p>Immunofluorescent staining of bile canaliculus using 2 different anti-CD25 monoclonal antibodies</p>
<p>Similar canalicular staining patterns were revealed by immunofluorescence assay using 2 different mouse anti-CD25 monoclonal antibodies: (A) clone IL2R.1, 1:200, Labvision, magnification: 200× (blue arrow); (B) clone 4c9, 1:200, Zymed, magnification: 400× (blue arrow).</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig5.tif"/>
</fig>
</sec>
<sec id="section13-1066896912444158">
<title>Ultrastructure Analysis of CD25</title>
<p>Analysis by electron microscopy revealed an obvious amorphous electron-dense deposit at the bile canaliculus (indicated by blue arrows, <xref ref-type="fig" rid="fig6-1066896912444158">Figure 6</xref>).</p>
<fig id="fig6-1066896912444158" position="float">
<label>Figure 6.</label>
<caption>
<p>A representative electron micrograph with an obvious amorphous electron-dense deposit at the bile canaliculi. Magnification: 6000× (blue arrows)</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig6.tif"/>
</fig>
</sec>
<sec id="section14-1066896912444158">
<title>CD25 Expression and Liver Disease</title>
<p>We analyzed hepatic CD25 expression levels in bile canaliculi of liver tissues collected from normal patients and those diagnosed with one of several liver diseases. CD25 expression did not differ significantly with disease state (<xref ref-type="fig" rid="fig7-1066896912444158">Figure 7</xref>).</p>
<fig id="fig7-1066896912444158" position="float">
<label>Figure 7.</label>
<caption>
<p>Expression levels of CD25 in normal and diseased liver tissues. Each data point represents the CD25 level of a patient. No significant differences in expression were observed</p>
</caption>
<graphic xlink:href="10.1177_1066896912444158-fig7.tif"/>
</fig>
</sec>
</sec>
<sec id="section15-1066896912444158" sec-type="discussion">
<title>Discussion</title>
<p>In the present study, we provide evidence that CD25 is a good marker of bile canaliculus. To the best of our knowledge, this is the first study to identify CD25 as a marker of bile canaliculus. Moreover, we observed no differences in CD25 expression in bile canaliculus among liver tissues from patients with diverse liver diseases and normal specimens. Thus, CD25 could be a very useful candidate antigen for immunochemistry and immunofluorescence analyses of bile canaliculus in both basic and clinical hepatic investigations.</p>
<p>Currently, several antigens have been used to identify bile canaliculus. Among these antigens, CEA has been the most accepted. As early as the 1979s and 1980s, an anti-CEA polyclonal antibody (p-CEA) yielded bile canalicular staining in normal liver tissues and hepatic carcinomas.<sup><xref ref-type="bibr" rid="bibr8-1066896912444158">8</xref>,<xref ref-type="bibr" rid="bibr25-1066896912444158">25</xref>,<xref ref-type="bibr" rid="bibr26-1066896912444158">26</xref></sup> Up to now, numerous reports have used the p-CEA as an important tool to view the bile canaliculus.<sup><xref ref-type="bibr" rid="bibr7-1066896912444158">7</xref>,<xref ref-type="bibr" rid="bibr27-1066896912444158">27</xref><xref ref-type="bibr" rid="bibr28-1066896912444158"/>-<xref ref-type="bibr" rid="bibr29-1066896912444158">29</xref></sup> The phenomenon was thought to be mediated by the cross-reactivity between CEA and biliary glycoprotein<sup><xref ref-type="bibr" rid="bibr8-1066896912444158">8</xref></sup> or canalicular bile acid transporter/ecto-ATPase/cell CAM 105, which is a vital transporter located at the bile canaliculus.<sup><xref ref-type="bibr" rid="bibr30-1066896912444158">30</xref>,<xref ref-type="bibr" rid="bibr31-1066896912444158">31</xref></sup> However, some reports also demonstrate CEA staining in non-bile canaliculus locations. Sentani et al<sup><xref ref-type="bibr" rid="bibr32-1066896912444158">32</xref></sup> reported that p-CEA staining in liver could display a cytoplasmic pattern. In our study, we compared CD25 and CEA staining in normal liver tissues. In agreement with Sentani et al,<sup><xref ref-type="bibr" rid="bibr32-1066896912444158">32</xref></sup> we found that CEA was located not only at the bile canaliculus but also at some hepatic sinusoids. Thus, we think the nonspecific expression pattern of CEA may cause some inaccuracies in liver and biliary tract investigations.</p>
<p>In contrast, CD25 was mainly located at the bile canaliculus, which suggests that it may be a more specific and effective marker of bile canaliculus in immunohistochemistry and immunofluorescence analyses. Studies investigating the expression pattern of CD25 in liver are few. Some scholar found that CD25 (IL-2Rα) was expressed by endothelial cells in other organs. Ponsioen et al<sup><xref ref-type="bibr" rid="bibr33-1066896912444158">33</xref></sup> characterized the composition of the mononuclear infiltrate in bile canaliculus of primary sclerosing cholangitis. They did not find any signs of activation of the lymphocytic infiltrate of CD25 in liver sections.<sup><xref ref-type="bibr" rid="bibr33-1066896912444158">33</xref></sup> However, Davenport et al<sup><xref ref-type="bibr" rid="bibr34-1066896912444158">34</xref></sup> showed CD25 immunoreactive lymphocytes in liver and the biliary tree in extrahepatic biliary atresia. The cause of this discrepancy is not clear. In our study, we scarcely observed CD25-positive hepatocytes or lymphocyte infiltration in hepatocytes. In contrast, most CD25-labeled cells were densely distributed in the tube-like bile canaliculus. Moreover, in liver tissues from patients with hepatitis B, primary biliary cirrhosis, drug-induced hepatitis, infantile liver tissues, and chronic rejection after liver transplantation, there may be a large degree of lymphocytic infiltration. However, we did not find many CD25 positive cells among hepatocytes, and CD25 staining was limited to bile canaliculus, similar to our observations in normal liver tissue. Therefore, our results exclude CD25 staining in bile canaliculus as the consequence of an inflammatory liver disease. We also did not find any differences in the density of CD25 staining among normal liver tissue and tissue from several different disease states, excluding the possibility of a confounding influence from hepatic infection. Thus, we believe CD25 is a promising marker of bile canaliculus.</p>
<p>Collectively, data support the conclusion that CD25 is a novel marker for bile canaliculus, and it can be used intensively in immunohistochemistry or immunofluorescence assays in both basic and clinical hepatic studies.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article:</p>
<p>This work was supported by the Instructive Grants of Wuxi City, Jiangsu Province (No. CSZ00722).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896912444158">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>N</given-names></name>
<name><surname>Tsukada</surname><given-names>N</given-names></name>
<name><surname>Smith</surname><given-names>CR</given-names></name>
<name><surname>Phillips</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Motility of bile canaliculi in the living animal: implications for bile flow</article-title>. <source>J Cell Biol</source>. <year>1991</year>;<volume>113</volume>:<fpage>1069</fpage>-<lpage>1080</lpage>.</citation>
</ref>
<ref id="bibr2-1066896912444158">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arias</surname><given-names>IM</given-names></name>
<name><surname>Che</surname><given-names>M</given-names></name>
<name><surname>Gatmaitan</surname><given-names>Z</given-names></name>
<name><surname>Leveille</surname><given-names>C</given-names></name>
<name><surname>Nishida</surname><given-names>T</given-names></name>
<name><surname>St Pierre</surname><given-names>M</given-names></name>
</person-group>. <article-title>The biology of the bile canaliculus, 1993</article-title>. <source>Hepatology</source>. <year>1993</year>;<volume>17</volume>:<fpage>318</fpage>-<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr3-1066896912444158">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stapelbroek</surname><given-names>JM</given-names></name>
<name><surname>van Erpecum</surname><given-names>KJ</given-names></name>
<name><surname>Klomp</surname><given-names>LW</given-names></name>
<name><surname>Houwen</surname><given-names>RH</given-names></name>
</person-group>. <article-title>Liver disease associated with canalicular transport defects: current and future therapies</article-title>. <source>J Hepatol</source>. <year>2010</year>;<volume>52</volume>:<fpage>258</fpage>-<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr4-1066896912444158">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Novikoff</surname><given-names>AB</given-names></name>
<name><surname>Essner</surname><given-names>E</given-names></name>
</person-group>. <article-title>The liver cell. Some new approaches to its study</article-title>. <source>Am J Med</source>. <year>1960</year>;<volume>29</volume>:<fpage>102</fpage>-<lpage>131</lpage>.</citation>
</ref>
<ref id="bibr5-1066896912444158">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Birbeck</surname><given-names>MS</given-names></name>
<name><surname>Cartwright</surname><given-names>P</given-names></name>
<name><surname>Hall</surname><given-names>JG</given-names></name>
<name><surname>Orlans</surname><given-names>E</given-names></name>
<name><surname>Peppard</surname><given-names>J</given-names></name>
</person-group>. <article-title>The transport by hepatocytes of immunoglobulin A from blood to bile visualized by autoradiography and electron microscopy</article-title>. <source>Immunology</source>. <year>1979</year>;<volume>37</volume>:<fpage>477</fpage>-<lpage>484</lpage>.</citation>
</ref>
<ref id="bibr6-1066896912444158">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sormunen</surname><given-names>R</given-names></name>
<name><surname>Eskelinen</surname><given-names>S</given-names></name>
<name><surname>Lehto</surname><given-names>VP</given-names></name>
</person-group>. <article-title>Bile canaliculus formation in cultured HEPG2 cells</article-title>. <source>Lab Invest</source>. <year>1993</year>;<volume>68</volume>:<fpage>652</fpage>-<lpage>662</lpage>.</citation>
</ref>
<ref id="bibr7-1066896912444158">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kitagawa</surname><given-names>Y</given-names></name>
<name><surname>Iwai</surname><given-names>M</given-names></name>
<name><surname>Muramatsu</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues</article-title>. <source>Histopathology</source>. <year>2002</year>;<volume>40</volume>:<fpage>472</fpage>-<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr8-1066896912444158">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Svenberg</surname><given-names>T</given-names></name>
<name><surname>Hammarstrom</surname><given-names>S</given-names></name>
<name><surname>Zeromski</surname><given-names>J</given-names></name>
</person-group>. <article-title>Immunofluorescence studies on the occurrence and localization of the CEA-related biliary glycoprotein I (BGP I) in normal human gastrointestinal tissues</article-title>. <source>Clin Exp Immunol</source>. <year>1979</year>;<volume>36</volume>:<fpage>436</fpage>-<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr9-1066896912444158">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herrema</surname><given-names>H</given-names></name>
<name><surname>Czajkowska</surname><given-names>D</given-names></name>
<name><surname>Theard</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Rho kinase, myosin-II, and p42/44 MAPK control extracellular matrix-mediated apical bile canalicular lumen morphogenesis in HepG2 cells</article-title>. <source>Mol Biol Cell</source>. <year>2006</year>;<volume>17</volume>:<fpage>3291</fpage>-<lpage>3303</lpage>.</citation>
</ref>
<ref id="bibr10-1066896912444158">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cai</surname><given-names>SY</given-names></name>
<name><surname>Gautam</surname><given-names>S</given-names></name>
<name><surname>Nguyen</surname><given-names>T</given-names></name>
<name><surname>Soroka</surname><given-names>CJ</given-names></name>
<name><surname>Rahner</surname><given-names>C</given-names></name>
<name><surname>Boyer</surname><given-names>JL</given-names></name>
</person-group>. <article-title>ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained</article-title>. <source>Gastroenterology</source>. <year>2009</year>;<volume>136</volume>:<fpage>1060</fpage>-<lpage>1069</lpage>.</citation>
</ref>
<ref id="bibr11-1066896912444158">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nobili</surname><given-names>V</given-names></name>
<name><surname>Di Giandomenico</surname><given-names>S</given-names></name>
<name><surname>Francalanci</surname><given-names>P</given-names></name>
<name><surname>Callea</surname><given-names>F</given-names></name>
<name><surname>Marcellini</surname><given-names>M</given-names></name>
<name><surname>Santorelli</surname><given-names>FM</given-names></name>
</person-group>. <article-title>A new ABCB11 mutation in two Italian children with familial intrahepatic cholestasis</article-title>. <source>J Gastroenterol</source>. <year>2006</year>;<volume>41</volume>:<fpage>598</fpage>-<lpage>603</lpage>.</citation>
</ref>
<ref id="bibr12-1066896912444158">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mottino</surname><given-names>AD</given-names></name>
<name><surname>Crocenzi</surname><given-names>FA</given-names></name>
<name><surname>Pozzi</surname><given-names>EJ</given-names></name>
<name><surname>Veggi</surname><given-names>LM</given-names></name>
<name><surname>Roma</surname><given-names>MG</given-names></name>
<name><surname>Vore</surname><given-names>M</given-names></name>
</person-group>. <article-title>Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2005</year>;<volume>288</volume>:<fpage>G327</fpage>-<lpage>G336</lpage>.</citation>
</ref>
<ref id="bibr13-1066896912444158">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waldmann</surname><given-names>TA</given-names></name>
</person-group>. <article-title>The multi-subunit interleukin-2 receptor</article-title>. <source>Annu Rev Biochem</source>. <year>1989</year>;<volume>58</volume>:<fpage>875</fpage>-<lpage>911</lpage>.</citation>
</ref>
<ref id="bibr14-1066896912444158">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Minami</surname><given-names>Y</given-names></name>
<name><surname>Kono</surname><given-names>T</given-names></name>
<name><surname>Miyazaki</surname><given-names>T</given-names></name>
<name><surname>Taniguchi</surname><given-names>T</given-names></name>
</person-group>. <article-title>The IL-2 receptor complex: its structure, function, and target genes</article-title>. <source>Annu Rev Immunol</source>. <year>1993</year>;<volume>11</volume>:<fpage>245</fpage>-<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr15-1066896912444158">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turka</surname><given-names>LA</given-names></name>
<name><surname>Walsh</surname><given-names>PT</given-names></name>
</person-group>. <article-title>IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells</article-title>. <source>Front Biosci</source>. <year>2008</year>;<volume>13</volume>:<fpage>1440</fpage>-<lpage>1446</lpage>.</citation>
</ref>
<ref id="bibr16-1066896912444158">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>MH</given-names></name>
<name><surname>Gu</surname><given-names>DN</given-names></name>
<name><surname>Braddock</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases</article-title>. <source>Expert Opin Ther Targets</source>. <year>2008</year>;<volume>12</volume>:<fpage>313</fpage>-<lpage>326</lpage>.</citation>
</ref>
<ref id="bibr17-1066896912444158">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Letourneau</surname><given-names>S</given-names></name>
<name><surname>Krieg</surname><given-names>C</given-names></name>
<name><surname>Pantaleo</surname><given-names>G</given-names></name>
<name><surname>Boyman</surname><given-names>O</given-names></name>
</person-group>. <article-title>IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets</article-title>. <source>J Allergy Clin Immunol</source>. <year>2009</year>;<volume>123</volume>:<fpage>758</fpage>-<lpage>762</lpage>.</citation>
</ref>
<ref id="bibr18-1066896912444158">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mottet</surname><given-names>C</given-names></name>
<name><surname>Golshayan</surname><given-names>D</given-names></name>
</person-group>. <article-title>CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use</article-title>. <source>Swiss Med Wkly</source>. <year>2007</year>;<volume>137</volume>:<fpage>625</fpage>-<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr19-1066896912444158">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Desmet</surname><given-names>VJ</given-names></name>
<name><surname>Gerber</surname><given-names>M</given-names></name>
<name><surname>Hoofnagle</surname><given-names>JH</given-names></name>
<name><surname>Manns</surname><given-names>M</given-names></name>
<name><surname>Scheuer</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>Classification of chronic hepatitis: diagnosis, grading and staging</article-title>. <source>Hepatology</source>. <year>1994</year>;<volume>19</volume>:<fpage>1513</fpage>-<lpage>1520</lpage>.</citation>
</ref>
<ref id="bibr20-1066896912444158">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harrington</surname><given-names>EP</given-names></name>
<name><surname>Zhao</surname><given-names>C</given-names></name>
<name><surname>Fancy</surname><given-names>SP</given-names></name>
<name><surname>Kaing</surname><given-names>S</given-names></name>
<name><surname>Franklin</surname><given-names>RJ</given-names></name>
<name><surname>Rowitch</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination</article-title>. <source>Ann Neurol</source>. <year>2010</year>;<volume>68</volume>:<fpage>703</fpage>-<lpage>716</lpage>.</citation>
</ref>
<ref id="bibr21-1066896912444158">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>P</given-names></name>
<name><surname>Xu</surname><given-names>TY</given-names></name>
<name><surname>Guan</surname><given-names>YF</given-names></name>
<name><surname>Su</surname><given-names>DF</given-names></name>
<name><surname>Fan</surname><given-names>GR</given-names></name>
<name><surname>Miao</surname><given-names>CY</given-names></name>
</person-group>. <article-title>Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide</article-title>. <source>Cardiovasc Res</source>. <year>2009</year>;<volume>81</volume>:<fpage>370</fpage>-<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr22-1066896912444158">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>P</given-names></name>
<name><surname>Yang</surname><given-names>FJ</given-names></name>
<name><surname>Du</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction</article-title>. <source>Mol Med</source>. <year>2011</year>;<volume>17</volume>:<fpage>523</fpage>-<lpage>532</lpage>.</citation>
</ref>
<ref id="bibr23-1066896912444158">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>P</given-names></name>
<name><surname>Xu</surname><given-names>TY</given-names></name>
<name><surname>Guan</surname><given-names>YF</given-names></name>
<etal/>
</person-group>. <article-title>Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway</article-title>. <source>Ann Neurol</source>. <year>2011</year>;<volume>69</volume>:<fpage>360</fpage>-<lpage>374</lpage>.</citation>
</ref>
<ref id="bibr24-1066896912444158">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>P</given-names></name>
<name><surname>Guan</surname><given-names>YF</given-names></name>
<name><surname>Du</surname><given-names>H</given-names></name>
<name><surname>Zhai</surname><given-names>QW</given-names></name>
<name><surname>Su</surname><given-names>DF</given-names></name>
<name><surname>Miao</surname><given-names>CY</given-names></name>
</person-group>. <article-title>Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia</article-title>. <source>Autophagy</source>. <year>2012</year>;<volume>8</volume>:<fpage>77</fpage>-<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr25-1066896912444158">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koelma</surname><given-names>IA</given-names></name>
<name><surname>Nap</surname><given-names>M</given-names></name>
<name><surname>Huitema</surname><given-names>S</given-names></name>
<name><surname>Krom</surname><given-names>RA</given-names></name>
<name><surname>Houthoff</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters</article-title>. <source>Arch Pathol Lab Med</source>. <year>1986</year>;<volume>110</volume>:<fpage>1035</fpage>-<lpage>1040</lpage>.</citation>
</ref>
<ref id="bibr26-1066896912444158">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Machinami</surname><given-names>R</given-names></name>
<name><surname>Oono</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma</article-title>. <source>Virchows Arch A Pathol Anat Histopathol</source>. <year>1987</year>;<volume>412</volume>:<fpage>111</fpage>-<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr27-1066896912444158">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamanoi</surname><given-names>K</given-names></name>
<name><surname>Kondoh</surname><given-names>Y</given-names></name>
<name><surname>Fujii</surname><given-names>T</given-names></name>
<name><surname>Kurihara</surname><given-names>N</given-names></name>
<name><surname>Mukai</surname><given-names>M</given-names></name>
<name><surname>Sakamoto</surname><given-names>M</given-names></name>
</person-group>. <article-title>Hepatoid adenocarcinoma of the stomach with multi-nucleated giant cell proliferation in a 100-year-old man</article-title>. <source>Pathol Int</source>. <year>2010</year>;<volume>60</volume>:<fpage>750</fpage>-<lpage>754</lpage>.</citation>
</ref>
<ref id="bibr28-1066896912444158">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Otsuki</surname><given-names>Y</given-names></name>
<name><surname>Shimizu</surname><given-names>S</given-names></name>
<name><surname>Hosoda</surname><given-names>Y</given-names></name>
<name><surname>Nagasawa</surname><given-names>M</given-names></name>
<name><surname>Sato</surname><given-names>Y</given-names></name>
<name><surname>Kobayashi</surname><given-names>H</given-names></name>
</person-group>. <article-title>Hepatocellular carcinoma with mesothelioma-like dissemination</article-title>. <source>Pathol Int</source>. <year>2005</year>;<volume>55</volume>:<fpage>738</fpage>-<lpage>744</lpage>.</citation>
</ref>
<ref id="bibr29-1066896912444158">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oliveira</surname><given-names>AM</given-names></name>
<name><surname>Erickson</surname><given-names>LA</given-names></name>
<name><surname>Burgart</surname><given-names>LJ</given-names></name>
<name><surname>Lloyd</surname><given-names>RV</given-names></name>
</person-group>. <article-title>Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA</article-title>. <source>Am J Surg Pathol</source>. <year>2000</year>;<volume>24</volume>:<fpage>177</fpage>-<lpage>182</lpage>.</citation>
</ref>
<ref id="bibr30-1066896912444158">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sippel</surname><given-names>CJ</given-names></name>
<name><surname>Shen</surname><given-names>T</given-names></name>
<name><surname>Perlmutter</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Site-directed mutagenesis within an ectoplasmic ATPase consensus sequence abrogates the cell aggregating properties of the rat liver canalicular bile acid transporter/ecto-ATPase/cell CAM 105 and carcinoembryonic antigen</article-title>. <source>J Biol Chem</source>. <year>1996</year>;<volume>271</volume>:<fpage>33095</fpage>-<lpage>33104</lpage>.</citation>
</ref>
<ref id="bibr31-1066896912444158">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sippel</surname><given-names>CJ</given-names></name>
<name><surname>Dawson</surname><given-names>PA</given-names></name>
<name><surname>Shen</surname><given-names>T</given-names></name>
<name><surname>Perlmutter</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Reconstitution of bile acid transport in a heterologous cell by cotransfection of transporters for bile acid uptake and efflux</article-title>. <source>J Biol Chem</source>. <year>1997</year>;<volume>272</volume>:<fpage>18290</fpage>-<lpage>18297</lpage>.</citation>
</ref>
<ref id="bibr32-1066896912444158">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sentani</surname><given-names>K</given-names></name>
<name><surname>Oue</surname><given-names>N</given-names></name>
<name><surname>Sakamoto</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach</article-title>. <source>Mod Pathol</source>. <year>2008</year>;<volume>21</volume>:<fpage>464</fpage>-<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr33-1066896912444158">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ponsioen</surname><given-names>CY</given-names></name>
<name><surname>Kuiper</surname><given-names>H</given-names></name>
<name><surname>Ten Kate</surname><given-names>FJ</given-names></name>
<name><surname>van Milligen</surname><given-names>de</given-names></name>
<name><surname>Wit</surname><given-names>M</given-names></name>
<name><surname>van Deventer</surname><given-names>SJ</given-names></name>
<name><surname>Tytgat</surname><given-names>GN</given-names></name>
</person-group>. <article-title>Immunohistochemical analysis of inflammation in primary sclerosing cholangitis</article-title>. <source>Eur J Gastroenterol Hepatol</source>. <year>1999</year>;<volume>11</volume>:<fpage>769</fpage>-<lpage>774</lpage>.</citation>
</ref>
<ref id="bibr34-1066896912444158">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davenport</surname><given-names>M</given-names></name>
<name><surname>Gonde</surname><given-names>C</given-names></name>
<name><surname>Redkar</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia</article-title>. <source>J Pediatr Surg</source>. <year>2001</year>;<volume>36</volume>:<fpage>1017</fpage>-<lpage>1025</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>